WallStreetZen

NYSE: GSK
Glaxosmithkline Plc Earnings & Revenue

GSK past earnings growth

How has GSK's earnings growth performed historically?
Company
28.05%
Industry
13.35%
Market
37.79%
GSK's earnings have grown slower (-9.26% per year) than the US Drug Manufacturers - General industry average (4.06%)
Performance
GSK's earnings have grown slower (-9.26% per year) than the US market average (19.73%)
Performance
GSK's earnings growth is accelerating - its growth over the last year (28.05%) is above its 5-year compound annual rate (-9.26%)
Performance

GSK past revenue growth

How has GSK's revenue growth performed historically?
Company
5.17%
Industry
12.11%
Market
20.26%
GSK's revenue has grown slower (5.77% per year) than the US Drug Manufacturers - General industry average (5.94%)
Performance
GSK's revenue has grown slower (5.77% per year) than the US market average (18.37%)
Performance
GSK's revenue growth is slowing down - its growth over the last year (5.17%) is below its 5-year compound annual rate (5.77%)
Performance

GSK earnings and revenue history

Current Revenue
$46.7B
Current Earnings
$7.9B
Current Profit Margin
16.9%
GSK's has demonstrated consistent long-term earnings growth over the past 10 years (216.4%)
Performance

GSK Return on equity

Current Company
41.4%
Current Industry
35.6%
Current Market
49.8%
GSK's Return on Equity (41.4%) shows a company that is highly efficient at transforming shareholder equity into returns
Performance

GSK Return on assets

Current Company
7%
Current Industry
6.9%
Current Market
5.4%
GSK is generating lower Return on Assets (7%) than the US Drug Manufacturers - General industry average (7.12%)
Performance

GSK Return on capital employed

Current Company
12.39%
Current Industry
11.1%
GSK has gotten more efficient at generating Return on Capital (12.39%) compared to 3 years ago (12.15%)
Performance

Glaxosmithkline Earnings & Revenue FAQ

What were GSK's earnings last quarter?

Glaxosmithkline (NYSE: GSK) reported Q4 2020 earnings per share (EPS) of $0.37, up 46.3% year over year. Total Glaxosmithkline earnings for the quarter were $927.40 million. In the same quarter last year, Glaxosmithkline's earnings per share (EPS) was $0.69.

What was GSK's earnings growth in the past year?

As of Q2 2021, Glaxosmithkline's earnings has grown 28.05% year over year. This is 14.69 percentage points higher than the US Drug Manufacturers - General industry earnings growth rate of 13.35%. Glaxosmithkline's earnings in the past year totalled $7.88 billion.

What was GSK's revenue last quarter?

Glaxosmithkline (NYSE: GSK) reported Q4 2020 revenue of $11.97 billion up 2.24% year over year. In the same quarter last year, Glaxosmithkline's revenue was $11.71 billion.

What was GSK's revenue growth in the past year?

As of Q2 2021, Glaxosmithkline's revenue has grown 5.17% year over year. This is 6.93 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 12.11%. Glaxosmithkline's revenue in the past year totalled $46.71 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.